20 June 2023 : Original article
Survival analysis of transplant-associated thrombotic microangiopathy under different diagnostic criteria and the efficacy of plasma exchange
Yifan Xu 12ABCDEF, Yan Wei12BF, Lijun Wang2BC, Ning Lu2BD, Yongli Wu2BD, Liping Dou2AF, Daihong Liu 2AF, Meng Li2ADEF*, Chunji Gao2ADEFGDOI: 10.12659/AOT.939890
Ann Transplant 2023; 28:e939890
Table 2 Univariate analysis of the efficacy of PE for TA-TMA.
Variable | Response to PE | P value | |
---|---|---|---|
NR (n=12) | CR/PR (n=9) | ||
139.5 (41–591) | 67.0 (22–179) | ||
ABO compatibility | 8 (66.7%) | 7 (77.8%) | 0.659 |
HLA matched | 4 (33.3%) | 2 (22.2%) | 0.659 |
Sex matched | 8 (66.7%) | 6 (66.7%) | >0.99 |
III–IV aGVHD prior to TA-TMA, n (%) | 8 (66.7%) | 3 (33.3%) | 0.198 |
EBV/CMV infections preceding TA-TMA, n (%) | 10 (83.3%) | 7 (77.8%) | >0.99 |
Elevated total bilirubin | 8 (66.7%) | 1 (11.1%) | |
GI bleeding | 9 (75.0%) | 6 (66.7%) | >0.99 |
Proteinuria | 6 (50.0%) | 7 (77.8%) | |
Hypoproteinemia | 10 (83.3%) | 6 (66.7%) | 0.611 |
Hypertension | 4 (33.3%) | 4 (44.4%) | |
Renal or neurological dysfunction | 8 (66.7%) | 1 (11.1%) | |
Bacterial infection | 12 (100.0%) | 8 (88.9%) | 0.429 |
Hb (g/L), mean | 59.5±9.2 | 76.2±12.3 | |
PLT (×10/L), median | 11.5 (3–32) | 35 (7–165) | 0.577 |
LDH (U/L), median | 536.8 (196.6–1790.4) | 314.9 (244.9–665.0) | 0.286 |
Schistocytes (%), median | 1.5 (0.0–4.0) | 1.5 (0.0–2.6) | 0.583 |
TBIL (μmol/L), median | 40.4 (4.7–329.0) | 9.6 (4.7–34.7) | |
Initial volume of PE (L), median | 2.0 (1.2–4.0) | 2.4 (1.9–3.5) | 0.924 |
Cumulative volume of PE (L), median | 9.0 (1.7–25.2) | 15.3 (6.2–51.2) | 0.127 |
Number of PE sessions, median | 3.5 (1–11) | 6 (2–25) | 0.054 |
Data are presented as the mean±SD, median (range, minimum-maximum), or n (%). Significant P values are in bold type. HLA – human leukocyte antigen; TBI – total body irradiation; aGVHD – acute graft-versus-host disease; CMV – cytomegalovirus; EBV – Epstein-Barr virus; LDH – lactate dehydrogenase; TBIL – total bilirubin; PE – plasma exchange; GI – gastrointestinal; Hb – hemoglobin; PLT – platelet. |